KaloBios Pharma (KBIO) Could Drop 50% By Early Next Week: Tim Sykes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
No Bloomberg Interview Today: KaloBios' (KBIO) Shkreli
November 24, 2015 1:46 PM ESTKaloBios Pharma's (NASDAQ: KBIO) Martin Shkreli said the Bloomberg interview got cancelled for today but will probably be a go tomorrow.
TV schedule got warped so will probably do it tomorrow.
Martin Shkreli (@MartinShkreli) November 24, 2015... MoreKaloBios Pharma (KBIO) on Watch Ahead of Shkreli Interview
November 24, 2015 11:47 AM ESTKaloBios Pharma (NASDAQ: KBIO) remains in focus with CEO Martin Shkreli expected to appear on Bloomberg TV around noon. Shares of the stock are down around 9 percent heading into the interview.
... MoreKaloBios Pharma (KBIO) CEO Shkreli Bought 5,000 More Shares
November 24, 2015 11:23 AM ESTKaloBios Pharma (NASDAQ: KBIO) CEO Martin Shkreli bought more shares.
Shkreli purchased 5,000 shares on November 24 at $38.15 apiece, according to a Form 4 filed Tuesday.
... MoreKaloBios Pharma (KBIO) CEO Shkreli Highlights 'Most Important Paper' on Company
November 24, 2015 9:41 AM ESTKaloBios Pharma (NASDAQ: KBIO) CEO Martin Shkreli highlighted what he called "the most importation paper" on the company that people should read:
This is probably the most important paper on... More
Pre-Open Stock Movers 11/24: (SUNE) (TASR) (BDBD) Higher; (UNXL) (CHS) (KBIO) Lower (more...)
November 24, 2015 9:29 AM ESTUniPixel (NASDAQ: UNXL) 42.9% LOWER; announced that it entered into subscription agreements with investors for the sale of 9,625,871 units at a public offering price of $0.85 per Unit in a public offering resulting in expected gross proceeds to the Company of $8.1 million.
... MoreKaloBios Pharma (KBIO) CEO to Appear on Bloomberg TV
November 24, 2015 8:53 AM ESTKaloBios Pharma's (NASDAQ: KBIO) CEO Martin Shkreli will be on Bloomberg TV at around noon, he said via twitter.
I'll be on Bloomberg TV around noon, talking about my turnaround plan for $KBIO. Tune in!
Martin Shkreli (@MartinShkreli) November 24, 2015
KaloBios Pharma's (KBIO) Delisting Notification Comes as No Surprise
November 24, 2015 7:23 AM ESTKaloBios Pharma (Nasdaq: KBIO) shares are down around 9 percent following news that it received a delisting notice from the Nasdaq Stock Market. The notification comes following a sharp run higher as Martin Shkreli made a major investment in the company and was subsequently appointed as its CEO.
But, the delisting notification shouldn't come as a surprise to anyone following the stock. The company filed an... More
KaloBios Pharma (KBIO) Receives NASDAQ Delisting Notice
November 23, 2015 5:46 PM ESTThe NASDAQ Stock Market notified KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), by letter dated November 17, 2015, that the Company is not currently in compliance with Nasdaqs continued listing requirement set forth in Rule 5250(c)(1) of the Nasdaq Listing Rules (the Rules), due to its failure to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 (the 2015 Third Quarter 10-Q) with the Securities and Exchange Commission (the SEC).
Under the Rules, the Company has 60 calendar days from November 17, 2015 to submit a plan to Nasdaq to regain compliance with the Rules. The Company intends to file... More
Notable 52-Week Highs and Lows 11/23: (KBIO) (TSN) (EFUT) High; (ARP) (NM) (PCO) Lower
November 23, 2015 3:35 PM EST52-Week High:KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) $45.82. KaloBios ripping higher again as CEO Shkreli took an additional stake in the company. For more color, click here.
Tyson Foods (NYSE: TSN) $48.28. Tyson Foods reported Q4 EPS of $0.83, which was $0.05 worse than the analyst estimate of $0.88. Revenue for the quarter came in at $10.5 billion... More
KaloBios Pharma (KBIO) CEO Shkreli Purchased 5,000 Shares
November 23, 2015 3:12 PM ESTKaloBios Pharma (NASDAQ: KBIO) CEO Martin Shkreli disclosed a recent stock purchase.
In a Form 4 filing made today, Shkreli purchased 5,000 shares of the company's stock on November 20th for $18.88 per share.
The filing is embedded below:
... MoreUnusual 11 Mid-Day Movers 11/23: (KBIO) (EFUT) (NBG) Higher; (ARP) (PCO) (PRQR) Lower
November 23, 2015 1:04 PM ESTKaloBios Pharma (Nasdaq: KBIO) 105.5% HIGHER; gaining once again as volatility in the name continues. The company named Martin Shkreli as CEO last week following a large investment.
eFuture Information Technology Inc. (Nasdaq: EFUT) 59.0% HIGHER; reported Q3 net loss of RMB3.9 million (US$0.6 million), compared to a net loss of RMB 1.8 million in the third quarter 2014. Third quarter total revenue increased 6% year-over-year to RMB36.1 million.
Shkreli Rubs Salt in KaloBios Pharma (KBIO) Short Sellers' Wounds
November 23, 2015 12:55 PM ESTKaloBios Pharma (NASDAQ: KBIO) new CEO Martin Shkreli just tweeted a picture of himself and others at the company's headquarters captioned "turnaround in progress."
Shares have surged from $0.90 to over $45 in a few days amid news a Shkreli group has accumulated... More
Cleveland Biolabs (CBLI) Sees Mid-Day Upside on KBIO Comparison
November 23, 2015 12:36 PM ESTCleveland Biolabs (NASDAQ: CBLI) bumps higher mid-day as company is compared to KaloBios Pharma (NASDAQ: KBIO).
... MoreKaloBios Pharma (KBIO) Halted Again on LUDP
November 23, 2015 12:18 PM ESTKaloBios Pharma (NASDAQ: KBIO) is again halted on limit-up, limit-down trading pause. Last up 109.32%
... More